Evaluation of carotid intima-media thickness, left ventricular mass and left atrium diameter in chronic liver diseases

Life Science Journal

Volumn 9, Issue 2, 2012, Pages 1199-1206

  Khalik, Ashraf Abdel ^a   Metwaly, Amna ^a   Nasr, Fatma Mohammad ^a   Damarawy, Mervat Al ^a   Youssef, Ayman ^a  

^a THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Carotid intima media thickness; Left atrium; Left ventricular end systolic diameter; Left ventricular hypertrophy; Left ventricular mass; Liver cirrhosis; Nonalcoholic fatty liver disease

Indexed keywords

EID: 84874827774     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Al-Hamoudi W. (2010). Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J Gastroenterol.; 16 (3): 145-53
2. Matsumori A., Yutani C., Ikeda Y., Kawai S. and Sosoyama S. (2000). Hepatitis C virus from the hearts of patients with mycarditis and cardiomyopathy. Lab. Invest.: 80: 1137-1142.
3. Shah P. K. (2001). Link between infection and atherosclerosis: who are the culprits? viruses, bacteria both or neither. Circulation, 103: 5-6.
4. Ishizaka N., Ishizaka Y. and Takahoshi E. (2002). Association between hepatitis C virus seropositivity, carotid artery plaque and intimamedia thickening. Lancet: 329: 133-135
5. Vassalle C., Masini S., Bianchi F. and Zucchelli G. C. (2004). Evidence for association between hepatitis C viruv seropositivity and coronary artery disease. Heart, 90: 565-566.
6. Carey W, Dumot J., Pimentel R., et al. (1995). The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation, 59: 859-64
7. Marchesini G., Ronchi M., Forlani G., Bugianesi E., Bianchi G., Fabbr A., et al. (1999). Cardiovascular disease in cirrhosis-a pointprevalence study in relation to glucose tolerance. Am. J. Gastroenterol., 94: 655-662
8. Kalaitzakis E., Rosengren A., Skommevik T. and Bjrnsson E. (2010). Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci.; 55 (2): 467-75
9. de Groot E., Hovingh GK., Wiegman A., et al. (2004). Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation; 109 23 suppl 1: III33-III38.
10. Lim T., Lim E., Dwivedi G., Kooner J., Senior R. (2008). Normal value of carotid intima-media thickness-a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr., 21 (2): 112-116
11. Møller S., Søndergaard L., Møgelvang J., et al. (1995). Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology; 22: 472-8.
12. Wong F., Liu P., Lilly L., et al. (1999). Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci; 97: 259-67.
13. Bernal V., Pascual I., Lanas A., Esquivias P., Piazuelo E., Garcia-Gil FA., Lacambra I, and Simon MA. (2012). Cardiac function and aminoterminal pro-brain natriuretic peptide levels in liver-transplanted cirrhotic patients. Clin Transplant., 26: 111-116.
14. Perello A, Inserte J, Godoy A, et al. (2000). Cardiac structure and function in experimental intra-hepatic portal hypertension. J Hepatol.; 32: 65.
15. De Marco, Marina, Chinali, Marcello, Romano, Carmel, Benincasa, Margherita, D'Addeo, Gianpaolo, D'Agostino, Luciano, de Simone and Giovann. (2008). Increased left ventricular mass in pre-liver transplantation cirrhotic patients. February; Volume 9-Issue 2-p 142-146
16. Kelbæk H, Eriksen J, Brynjolf I, et al. (1984). Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol.; 54: 852-5.
17. Rector WG and Hossack KF. (1988). Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished "effective" arterial blood volume? Gastroenterology; 95: 1658-63.
18. Rector WG Jr, Adair O, Hossack KF, et al. (1990). Atrial volume in cirrhosis: relationship to blood volume and plasma concentrations of atrial natriuretic factor. Gastroenterology; 99: 766-70.
19. Fu-Rong Sun, Ying Wang, Bing-Yuan Wang, Jing Tong, Dai Zhang and Bing Chang Shenyang, China. (2011). Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease. Hepatobiliary Pancreat Dis Int.; 10: 50-54
20. Zamirian M., Asloni A. and Sharifkazen M. B. (2008). Prediction of intra-pulmonary right to left shunt with left atrial size in patient with liver cirrhosis. Eur. J. Echocardiogr; 9: 1-4.
21. Bellentani S, Scaglioni F, Marino M and Bedogni G. (2010). Epidemiology of non-alcoholic fatty liver disease. Dig Dis.; 28 (1): 155-161
22. Balmer ML and Dufour JF. (2011). Non-alcoholic steatohepatitis-from NAFLD to MAFLD. Ther Umsch.; 68 (4): 183-188.
23. Wong VW, Wong GL, Yip GW, et al. (2011). Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut.; 60 (12): 1721-7
24. Tarquini R, Lazzeri C, Boddi M, Marra F, Abbate R and Gensini GF. (2010). Non-alcoholic fatty liver disease: a new challenge for cardiologists. G Ital Cardiol (Rome); 11 (9): 660-669.
25. Mohamadi A, Ghasemi-Rad M, Zahedi H, Toldi G and Alinia T. (2011). Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. Med Ultrason.; 13 (3): 200-206
26. Targher G, Marra F, Marchesini G. (2008). Increased risk of cardiovascular disease in nonalcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia.; 51 (11): 1947-1953
27. Kim JH, Kim SY, Jung ES, et al. (2011). Carotid intima-media thickness is increased not only in non-alcoholic Fatty liver disease patients but also in alcoholic Fatty liver patients. Digestion.; 84 (2): 149-155.
28. Sookoian S. and Pirola CJ. (2008). Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol.; 49 (4): 600-607.
29. Choi SY, Kim D, Kang JH, et al. (2008). Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of nonalcoholic fatty liver disease to carotid atherosclerosis. Korean J Hepatol.; 14 (1): 77-88.
30. Afshin Mohammadi, Ali Bazazi, and Mohammad Ghasemi-rad. (2011). Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease. Int J Gen Med.; 4: 717-722.
31. Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, Lutaty G, Melzer E, Orr A, Caspi A, Malnick S. (2006). Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol.; 40 (10): 949-55.
32. Fallo F., Dalla Pozza A., Sonino N., Lupia M., Tona F., Federspil G., Ermani M., Catena C. and Soardo G. (2009). Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutrition, Metabolism and Cardiovascular Diseases: 19, 9: 646-653.
33. Gottdiener J. S., Bendnarz I., Devereaux R. et al. (2004). American Society of Echocardiography recommendations for use of echocardiography in clinical trials. Journal of American Society of Echocardiography; 17: 1086: 1119
34. Devereaux RB, Alonso DR, Lutas EM, et al. (1986). Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. American Journal of Cardiology; 57: 450-458.
35. Teichholz LE, Kreulen T, Herman MV and Gorlin. (1976). Prblems in echocardiographic volume determinations. Am J Cardiol. Jan; 37 (1): 7-11.
36. Plotkin JS, Benitez RM, Kuo PC et al. (1998). Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg.; 4: 253-7.
37. Szollar L. and Orv Hetil. (2011). Fatty liver and global cardiometabolic risk. Hungarian; 15 (47): 1946-1950.
38. Nseir W., Shalata A., Marmor A. and Assy N. (2011). Mechanisms Linking Non-alcoholic Fatty Liver Disease with Coronary Artery Disease. Dig Dis Sci.; 56 (12): 3439-49.
39. Targher G, Bertolini L, Padovani R, et al. (2006). Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care; 29 (6): 1325-1330
40. Ramilli S, Pretolani S, Muscari A, Pacelli B, Arienti V. (2009). Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol.; 15 (38): 4770-4774.
41. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK jr, Bommer W, Price TR, Gardin JM, Savage PJ. (1992). Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke 23: 1752-1760.
42. Lunseth JH, Olmstead EG, Forks G, Abboud F. (1958). A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. Arch Intern Med: 102: 405.
43. Pozzi M, Carugo S, Boari G et al. (1997). Evidence of functional and structural cardiac abnormalies in cirrhosis patients with and without ascites. Hepatology: 26: 1131.
44. Castellanos-Pallares G, Ortiz-Olvera NX, Gómez-Jiménez LM, Cabrera-Muñoz ML, Méndez-Navarro J, Morán-Villota S, Dehesa-Violante M. (2011). Anatomical cardiac alterations in liver cirrhosis: An autopsy study. Ann Hepatol; 10 (3): 321-6
45. Lorell BH and Carabello BA. (2000). Left ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation, 102: 470.
46. Levy D, Garrison RJ, Savage DD, Kannel WB, and Castelli WP. (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med., 322: 1561.
47. Mantovani A, G. Zoppini G., Targher G., Golia G., and Bonora E. (2012). Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals. J. Endocrinol. Invest., 35: 215-218
48. Fotbolcu H, Yakar T, Duman D, Karaahmet T, Tigen K, Cevik C, Kurtoglu U and Dindar I. (2010). Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol. J.; 17 (5): 457-63.
49. Soyoral Y, Süner A, Ki{dotless}di{dotless}r V, Ari{dotless}türk Z, Balakan O and Deǧertekin H. (2004). The effects of viral cirrhosis on cardiac ventricular function. Eur J Gen Med.; 1 (2): 15-18
50. Bonapace S., Perseghin G., Molon G., Canali G., Bertolini L., et al. (2012). Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes. Diabetes Care 35 (2): 389-395.
51. Ramachandran S. Vasan, M. D., Martin G. Larson, Sc. D., Emelia J. Benjamin, M. D., Sc. M., Jane C. Evans, M. P. H., and Daniel Levy, M. D. (1997). Left Ventricular Dilatation and the Risk of Congestive Heart Failure in People without Myocardial Infarction. N Engl J Med; 336: 1350-1355
52. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Aakhus T. (1993). Heart volume and cardiovascular mortality: a 16 year follow-up study of 1984 healthy middle-aged men. Eur Heart J; 14: 592-596
53. Lauer MS, Evans JC, Levy D. (1992). Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol; 70: 1180-118